PS-3-2 High-Throughput Phenotypic Screening Campaign of 1,954 FDA-Approved Drugs Reveals 41 Hits With Anti-Myofibroblast Activity in an in Vitro Model of Peyronie's Disease

Autor:	Asif Muneer, Selim Cellek, Marcus M. Ilg, Nim Christopher, A.R. Lapthorn, David Ralph
Rok vydání:	2020
Předmět:	business.industry Urology Endocrinology Diabetes and Metabolism Phenotypic screening medicine.disease In vitro model Psychiatry and Mental health Endocrinology Reproductive Medicine Cancer research medicine Peyronie's disease business Myofibroblast Throughput (business)
Zdroj:	The Journal of Sexual Medicine. 17:S129-S129
ISSN:	1743-6109 1743-6095
DOI:	10.1016/j.jsxm.2020.04.035
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d38b3b486d4986b146727c4048a98b5c https://doi.org/10.1016/j.jsxm.2020.04.035 Zobrazit plný text záznamu